Follow us...

 

Search News Archives

Channels

News

 

 

View Channel

Laboratory Products

 

 

View Channel

Special Offers and Promotions

 

Microscopy | Image Analysis

 

 

View Channel

Separation Science

 

 

View Channel

Coronavirus (COVID-19)

 

 

View Channel

Research & Case Studies

 

 

View Channel

Conferences | Events

FUJIFILM Irvine Scientific Expands its Armstrong R&D Cell Culture Center of Excellence to Accelerate New Product Development and Broaden Service Offerings

publication date: Nov 15, 2021
 | 
author/source: FUJIFILM Irvine Scientific

fujifilm-irvine-scientific-expands-its-armstrong-rampd

 

FUJIFILM Irvine Scientific, Inc., a world leader in providing cell culture solutions for Life Science and Medical markets, announced the expansion of its Armstrong R&D Center of Excellence at its headquarters in California. This expansion marks an ongoing commitment to the advancement of discovery research, bioproduction, cell and gene therapy, assisted reproductive technologies and cytogenetics in its Life Sciences and Medical Media divisions. Leveraging a deep understanding of cell biology and cell culture solutions, FUJIFILM Irvine Scientific continues to expand its diverse offering of specialty media, technologies, and custom media services.

“With society’s increasing demand for global access to more high-quality, cost-effective vaccines, biopharmaceuticals, cell-based therapies, gene therapies, and in-vitro fertilization procedures, the need for a broadened focus on innovation is pivotal to expedite critical product and technology development. The expansion project will more than double the R&D facility’s footprint and will allow for more enhanced technical collaboration between R&D experts and customers to develop personalized solutions and enhance partnership opportunities.” said Bob Newman, chief scientific officer, FUJIFILM Irvine Scientific.

With significant sales growth in the past year, and new manufacturing capabilities in Europe, this expansion will be essential to the success of new programs and initiatives FUJIFILM Irvine Scientific offers, including Manufacturing Sciences and Technologies (MSAT), Single-Use technology development, and automation platforms for media development. The expanded footprint will also include dedicated space for analytical chemistry, virology, Assisted Reproductive Technology (ART), and additional cell culture and molecular-based assay development, increasing employment opportunities and projecting a doubling of growth in R&D headcount by the close of 2022.

The construction began in October and is planned for completion by January, 2022.

 

 

About FUJIFILM

FUJIFILM Irvine Scientific, Inc., is a worldwide leader in the innovation and manufacture of cell culture media, reagents, and medical devices for researchers and clinicians. The company provides unrivaled service and quality to scientists working in biopharmaceuticals, cell therapy, and regenerative medicine, assisted reproductive technology and cytogenetics, and industrial cell culture for the large-scale production of biotherapeutics and vaccines. FUJIFILM Irvine Scientific adheres to both ISO and FDA regulations and operates dual cGMP manufacturing facilities in California, USA, and Tokyo, Japan. The company’s consultative philosophy combined with expertise in cell culture and compliance provides customers with unique capabilities and support. For over 50 years, FUJIFILM Irvine Scientific has remained uniquely flexible and focused on media while becoming a strategic global leader in media products and services.  FUJIFILM Irvine Scientific, Inc. is a subsidiary of FUJIFILM Holdings America Corporation reporting to FUJIFILM Holdings Corporation.


FUJIFILM Holdings Corporation, Tokyo, Japan, brings cutting edge solutions to a broad range of global industries by leveraging its depth of knowledge and fundamental technologies developed in its relentless pursuit of innovation. Its proprietary core technologies contribute to the various fields including healthcare, highly functional materials, document solutions, and imaging. These products and services are based on its extensive portfolio of chemical, mechanical, optical, electronic and imaging technologies. For the year ended March 31, 2021, the company had global revenues of $21 billion, at an exchange rate of 106 yen to the dollar. Fujifilm is committed to responsible environmental stewardship and good corporate citizenship.

 



 

Subscribe to any of our newsletters for the latest on new laboratory products, industry news, case studies and much more!

Newsletters from Lab Bulletin

 

Request your free copies HERE

 

 

 

Popular this Month

Top 10 most popular articles this month

 

Today's Picks

 

 


 

Looking for a Supplier?

Search by company or by product

 


Company Name:

Product:


 

 

 

 

Please note Lab Bulletin does not sell, supply any of the products featured on this website. If you have an enquiry, please use the contact form below the article or company profile and we will send your request to the supplier so that they can contact you directly.

Lab Bulletin is published by newleaf marketing communications ltd.


 

Media Partners